Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies
Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny, et al.
Archiv der Pharmazie (2021)
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 73
Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
Yingqian Zhang, Chenyuan Wu, Nana Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12724-12724
Open Access | Times Cited: 38
Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
Heba A. El Gizawy, Sylvia A. Boshra, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5844-5844
Open Access | Times Cited: 72
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 68
Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
Ahmed A. Al‐Karmalawy, Mai M. Farid, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6559-6559
Open Access | Times Cited: 67
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 54
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 54
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 47
Potential Valorization of Edible Nuts By-Products: Exploring the Immune-Modulatory and Antioxidants Effects of Selected Nut Shells Extracts in Relation to Their Metabolic Profiles
Mohamed A. Salem, Nora M. Aborehab, Ahmed A. Al‐Karmalawy, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 462-462
Open Access | Times Cited: 43
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41
In vitroand computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MProinhibitors
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 39
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 37
Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies
Samia M. Al-Muntaser, Ahmed A. Al‐Karmalawy, Abeer M. El‐Naggar, et al.
RSC Advances (2023) Vol. 13, Iss. 18, pp. 12184-12203
Open Access | Times Cited: 25
Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Hamada S. Abulkhair, Hoda S. El Saeed, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107105-107105
Closed Access | Times Cited: 6
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access
Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Mohammad Hayal Alotaibi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1098-1119
Open Access | Times Cited: 34
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 33
The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105968-105968
Closed Access | Times Cited: 30
Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 28
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 26
Design and Synthesis of 2-(4-Bromophenyl)Quinoline-4-Carbohydrazide Derivatives via Molecular Hybridization as Novel Microbial DNA-Gyrase Inhibitors
Hany M. Abd El‐Lateef, Ayman Abo Elmaaty, Lina M. A. Abdel Ghany, et al.
ACS Omega (2023) Vol. 8, Iss. 20, pp. 17948-17965
Open Access | Times Cited: 18
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 17
Pyrazolo[3,4-d]pyrimidine derivatives as EGFRT790M and VEGFR-2 dual TK inhibitors: Design, synthesis, molecular docking, ADMET profile and anticancer evaluations
Dina Adel, Khaled El‐Adl, Tamer Nasr, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136047-136047
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top